Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 4
2012 3
2013 8
2014 9
2015 11
2016 12
2017 21
2018 22
2019 7
2020 3
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 26827912

97 results
Results by year
Filters applied: . Clear all
Page 1
Engineering broadly neutralizing antibodies for HIV prevention and therapy.
Hua CK, Ackerman ME. Hua CK, et al. Adv Drug Deliv Rev. 2016 Aug 1;103:157-173. doi: 10.1016/j.addr.2016.01.013. Epub 2016 Jan 29. Adv Drug Deliv Rev. 2016. PMID: 26827912 Free PMC article. Review.
Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.
Jacob RA, Moyo T, Schomaker M, Abrahams F, Grau Pujol B, Dorfman JR. Jacob RA, et al. J Virol. 2015 May;89(10):5264-75. doi: 10.1128/JVI.00129-15. Epub 2015 Feb 11. J Virol. 2015. PMID: 25673728 Free PMC article.
Engineering and characterising a novel, highly potent bispecific antibody iMab-CAP256 that targets HIV-1.
Moshoette T, Ali SA, Papathanasopoulos MA, Killick MA. Moshoette T, et al. Retrovirology. 2019 Nov 8;16(1):31. doi: 10.1186/s12977-019-0493-y. Retrovirology. 2019. PMID: 31703699 Free PMC article.
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections.
Wagh K, Seaman MS, Zingg M, Fitzsimons T, Barouch DH, Burton DR, Connors M, Ho DD, Mascola JR, Nussenzweig MC, Ravetch J, Gautam R, Martin MA, Montefiori DC, Korber B. Wagh K, et al. PLoS Pathog. 2018 Mar 5;14(3):e1006860. doi: 10.1371/journal.ppat.1006860. eCollection 2018 Mar. PLoS Pathog. 2018. PMID: 29505593 Free PMC article.
Antibody-mediated prevention and treatment of HIV-1 infection.
Gruell H, Klein F. Gruell H, et al. Retrovirology. 2018 Nov 16;15(1):73. doi: 10.1186/s12977-018-0455-9. Retrovirology. 2018. PMID: 30445968 Free PMC article. Review.
Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes.
Kong R, Louder MK, Wagh K, Bailer RT, deCamp A, Greene K, Gao H, Taft JD, Gazumyan A, Liu C, Nussenzweig MC, Korber B, Montefiori DC, Mascola JR. Kong R, et al. J Virol. 2015 Mar;89(5):2659-71. doi: 10.1128/JVI.03136-14. Epub 2014 Dec 17. J Virol. 2015. PMID: 25520506 Free PMC article.
New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency.
Doria-Rose NA, Bhiman JN, Roark RS, Schramm CA, Gorman J, Chuang GY, Pancera M, Cale EM, Ernandes MJ, Louder MK, Asokan M, Bailer RT, Druz A, Fraschilla IR, Garrett NJ, Jarosinski M, Lynch RM, McKee K, O'Dell S, Pegu A, Schmidt SD, Staupe RP, Sutton MS, Wang K, Wibmer CK, Haynes BF, Abdool-Karim S, Shapiro L, Kwong PD, Moore PL, Morris L, Mascola JR. Doria-Rose NA, et al. J Virol. 2015 Oct 14;90(1):76-91. doi: 10.1128/JVI.01791-15. Print 2016 Jan 1. J Virol. 2015. PMID: 26468542 Free PMC article.
Use of broadly neutralizing antibodies for HIV-1 prevention.
Pegu A, Hessell AJ, Mascola JR, Haigwood NL. Pegu A, et al. Immunol Rev. 2017 Jan;275(1):296-312. doi: 10.1111/imr.12511. Immunol Rev. 2017. PMID: 28133803 Free PMC article. Review.
Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies.
Zhang Z, Li S, Gu Y, Xia N. Zhang Z, et al. Int J Mol Sci. 2016 Nov 18;17(11):1901. doi: 10.3390/ijms17111901. Int J Mol Sci. 2016. PMID: 27869733 Free PMC article. Review.
Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System.
Bhiman JN, Lynch RM. Bhiman JN, et al. Curr HIV/AIDS Rep. 2017 Apr;14(2):54-62. doi: 10.1007/s11904-017-0352-1. Curr HIV/AIDS Rep. 2017. PMID: 28349376 Free PMC article. Review.
97 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page